HERA HEALTH SOLUTIONS INC
Nanotechnology platform for reformulating existing therapeutics into long-acting, more effective drugs
- Sector
- Biotech
- Headquarters
- Frisco, TX
- Founded
- 2017
- Latest Form D
- $1.3M offered, Sep 2019
- Total capital
- $875K
- Federal grants
- $525K
- 2 awards · 2023–2025
- Rank in peer group#10 of 24
- Private capital raised
- $100K
- 2 Form D · last Sep 2019
- 86 months since last filing
- Federal contracts
- $250K
- 1 award · Defense
- Rank in Biotech#284 of 4373
- Granted patents
- 1
- 3 pending · first 2025
- Rank in peer group#5 of 24
Capital timeline
Latest events
- Federal contractDefense · Dha SBIR Phase 1 Proposal H243-001-0041, Titled "drug Delivery Platform For The Sustained Release Of An Hiv Vaccine", Medical R&d Contract$250K
- Federal grantDefense · Phase I · Dha SBIR Phase 1 Proposal H243-001-0041, Titled "drug Delivery Platform For The Sustained Release Of An Hiv Vaccine", Medical R&d Contract$250K
- Federal grantNSF · Phase I · SBIR Phase I:Bio-erodible Contraceptive-Releasing Implant$275K
- Offering registeredForm D · SEC · 2nd filing$1.3M
- Private capital raisedForm D · SEC · 1st filing$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 24 peers
Line = medianBiotech · Device
- Federal grants#10 · top 42%
- Granted patents#5 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Garrett WhitfieldResearcherExecutive Officer, DirectorLinked by 1 patent
- Garret WhitfieldExecutive Officer, DirectorNamed in SEC Form D filings
- Idicula MathewExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 4- PendingBioerodible Drug Delivery ImplantsUSPTOApplication 19072139
- GrantedBioerodible Drug Delivery ImplantsUSPTOUS 12,274,797
- PendingBioerodible Drug Delivery ImplantsUSPTOApplication 16029624
Show all 4 patent records
- Bioerodible Drug Delivery ImplantsJun 19, 2025 · Application 19072139Pending
- Bioerodible Drug Delivery ImplantsApr 15, 2025 · US 12,274,797Granted
- Bioerodible Drug Delivery ImplantsJan 10, 2019 · Application 16029624Pending
- Bioerodible Drug Delivery ImplantsApplication PCTUS2018041175Pending
Related companies, and why
- HERA HEALTH SOLUTIONS INC.Shares a founder: Sirsendu Bhowmick
- Optys Tech CorporationSimilar federal contract value in Biotech · $252K in contracts
- PROTEIN FOUNDRY, LLCSimilar federal contract value in Biotech · $250K in contracts
- GLYPHIC BIOTECHNOLOGIES, INC.Similar federal contract value in Biotech · $250K in contracts
- ERIVAN BIO, LLCSimilar federal contract value in Biotech · $250K in contracts
- LaCell LLCSimilar federal contract value in Biotech · $235K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .